Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Verve Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-04
Sale
2022-11-08
5:51 pm
Verve Therapeutics Inc. VERV Yeshwant Krishna
Director
10% Owner
48,583 $31.14 $1,512,806 4,308,630
(Indirect)
View
2022-11-04
Sale
2022-11-08
5:04 pm
Verve Therapeutics Inc. VERV GV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
97,166 $31.14 $3,025,611 4,308,630
(Indirect)
View
2022-11-02
Sale
2022-11-04
5:58 pm
Verve Therapeutics Inc. VERV Yeshwant Krishna
Director
10% Owner
78,220 $33.95 $2,655,330 4,386,850
(Indirect)
View
2022-11-02
Sale
2022-11-04
4:16 pm
Verve Therapeutics Inc. VERV GV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
156,440 $33.95 $5,310,658 4,386,850
(Indirect)
View
2022-10-31
Sale
2022-11-02
9:02 pm
Verve Therapeutics Inc. VERV Yeshwant Krishna
Director
10% Owner
85,659 $37.95 $3,250,496 4,472,510
(Indirect)
View
2022-10-31
Sale
2022-11-02
4:25 pm
Verve Therapeutics Inc. VERV GV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
171,319 $37.95 $6,501,031 4,472,510
(Indirect)
View
2022-10-28
Sale
2022-11-01
5:00 pm
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
10,000 $39.9 $399,000 93,624
(Direct)
View
2022-10-03
Sale
2022-10-05
5:00 pm
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $33.65 $1,682,622 778,828
(Indirect
Direct)
View
2022-09-23
Sale
2022-09-27
5:00 pm
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
60,000 $35.34 $2,120,392 126,822
(Direct)
View
2022-08-10
Sale
2022-08-11
5:00 pm
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $29.9 $1,495,000 807,258
(Indirect
Direct)
View
2022-07-20
Sale
2022-07-22
5:00 pm
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
20,000 $34.9 $698,000 8,228
(Direct)
View
2022-07-19
Sale
2022-07-21
5:00 pm
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $29.9 $1,495,000 857,258
(Indirect
Direct)
View
2022-07-13
Sale
2022-07-15
5:00 pm
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
10,000 $24.9 $249,000 143,624
(Direct)
View
2022-07-12
Sale
2022-07-14
5:24 pm
Verve Therapeutics Inc. VERV FMR LLC
10% Owner
163,000 $20.78 $3,386,520 570,729
(Indirect)
View
2022-07-01
Sale
2022-07-06
12:56 pm
Verve Therapeutics Inc. VERV FMR LLC
10% Owner
38,775 $15.66 $607,217 773,729
(Indirect)
View
2022-06-29
Sale
2022-07-01
2:54 pm
Verve Therapeutics Inc. VERV FMR LLC
10% Owner
53,219 $15.45 $822,476 772,504
(Indirect)
View
2022-05-12
Purchase
2022-05-13
4:37 pm
Verve Therapeutics Inc. VERV ADELMAN BURT A
Director
10,000 $12.15 $121,526 428,326
(Indirect)
View
2022-03-15
Purchase
2022-03-17
07:58 am
Verve Therapeutics Inc. VERV ADELMAN BURT A
Director
4,000 $21.38 $85,535 418,326
(Indirect)
View
2022-03-09
Sale
2022-03-11
5:59 pm
Verve Therapeutics Inc. VERV FMR LLC
10% Owner
3,971 $29.01 $115,199 825,723
(Indirect)
View
2022-02-09
Sale
2022-02-11
10:40 am
Verve Therapeutics Inc. VERV FMR LLC
10% Owner
13,190 $29.46 $388,577 829,694
(Indirect)
View
2022-02-01
Sale
2022-02-03
11:43 am
Verve Therapeutics Inc. VERV FMR LLC
10% Owner
35,574 $29.04 $1,033,069 842,884
(Indirect)
View
2022-01-26
Sale
2022-01-28
5:04 pm
Verve Therapeutics Inc. VERV FMR LLC
10% Owner
158,836 $31.12 $4,943,419 878,458
(Indirect)
View
2022-01-04
Sale
2022-01-06
4:36 pm
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
1,870 $39.9 $74,613 835,955
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-11-04
Other
2022-11-08
5:51 pm
N/A
N/A
Verve Therapeutics Inc. VERV Yeshwant Krishna
Director
10% Owner
48,583 $0 4,308,630
(Indirect)
View
2022-11-04
Other
2022-11-08
5:04 pm
N/A
N/A
Verve Therapeutics Inc. VERV GV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
48,583 $0 4,308,630
(Indirect)
View
2022-11-02
Other
2022-11-04
5:58 pm
N/A
N/A
Verve Therapeutics Inc. VERV Yeshwant Krishna
Director
10% Owner
78,220 $0 4,386,850
(Indirect)
View
2022-11-02
Other
2022-11-04
4:16 pm
N/A
N/A
Verve Therapeutics Inc. VERV GV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
78,220 $0 4,386,850
(Indirect)
View
2022-10-31
Other
2022-11-02
9:02 pm
N/A
N/A
Verve Therapeutics Inc. VERV Yeshwant Krishna
Director
10% Owner
85,660 $0 4,472,510
(Indirect)
View
2022-10-31
Other
2022-11-02
4:25 pm
N/A
N/A
Verve Therapeutics Inc. VERV GV 2017 GP L.L.C.
GV 2017 GP L.P.
GV 2017 L.P.
GV 2019 GP L.L.C.
GV 2019 GP L.P.
GV 2019 L.P.
Alphabet Inc.
Member of 10% Group
85,660 $0 4,472,510
(Indirect)
View
2022-10-28
Exercise
2022-11-01
5:00 pm
N/A
2029-09-16
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
10,000 $0 93,624
(Direct)
View
2022-10-28
Exercise
2022-11-01
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
10,000 $1.48 93,624
(Direct)
View
2022-10-03
Exercise
2022-10-05
5:00 pm
N/A
2029-04-14
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $0 778,828
(Direct)
View
2022-10-03
Exercise
2022-10-05
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $1.39 778,828
(Direct)
View
2022-09-23
Exercise
2022-09-27
5:00 pm
N/A
2029-09-16
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
60,000 $0 126,822
(Direct)
View
2022-09-23
Exercise
2022-09-27
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
60,000 $1.48 126,822
(Direct)
View
2022-08-25
Exercise
2022-08-29
5:00 pm
N/A
2028-11-07
Verve Therapeutics Inc. VERV Ashe Andrew D.
See Remarks
95,787 $0 446,786
(Direct)
View
2022-08-25
Exercise
2022-08-29
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Ashe Andrew D.
See Remarks
10,835 $2.87 446,786
(Direct)
View
2022-08-25
Exercise
2022-08-29
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Ashe Andrew D.
See Remarks
51,203 $1.39 446,786
(Direct)
View
2022-08-25
Exercise
2022-08-29
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Ashe Andrew D.
See Remarks
33,749 $1.48 446,786
(Direct)
View
2022-08-10
Exercise
2022-08-11
5:00 pm
N/A
2029-04-14
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $0 807,258
(Direct)
View
2022-08-10
Exercise
2022-08-11
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $1.39 807,258
(Direct)
View
2022-08-08
Option Award
2022-08-09
5:05 pm
N/A
2032-08-07
Verve Therapeutics Inc. VERV COATS LONNEL
Director
31,000 $0 31,000
(Direct)
View
2022-07-20
Exercise
2022-07-22
5:00 pm
N/A
2029-06-24
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
20,000 $0 8,228
(Direct)
View
2022-07-20
Exercise
2022-07-22
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
20,000 $1.39 8,228
(Direct)
View
2022-07-19
Exercise
2022-07-21
5:00 pm
N/A
2029-04-14
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $0 857,258
(Direct)
View
2022-07-19
Exercise
2022-07-21
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
50,000 $1.39 857,258
(Direct)
View
2022-07-07
Gift
2022-07-15
5:00 pm
N/A
2031-02-11
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
760,000 $0 1,817,129
(Direct)
View
2022-07-13
Exercise
2022-07-15
5:00 pm
N/A
2029-09-16
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
10,000 $0 143,624
(Direct)
View
2022-07-13
Exercise
2022-07-15
5:00 pm
N/A
N/A
Verve Therapeutics Inc. VERV Bellinger Andrew
CSO & CMO
10,000 $1.48 143,624
(Direct)
View
2022-06-09
Option Award
2022-06-13
5:01 pm
N/A
2032-06-08
Verve Therapeutics Inc. VERV Yeshwant Krishna
Director
10% Owner
15,500 $0 15,500
(Direct)
View
2022-06-09
Option Award
2022-06-13
5:00 pm
N/A
2032-06-08
Verve Therapeutics Inc. VERV Cumbo Alexander
Director
31,000 $0 31,000
(Direct)
View
2022-06-09
Option Award
2022-06-13
5:00 pm
N/A
2032-06-08
Verve Therapeutics Inc. VERV ADELMAN BURT A
Director
15,500 $0 15,500
(Direct)
View
2022-06-09
Option Award
2022-06-13
5:00 pm
N/A
2032-06-08
Verve Therapeutics Inc. VERV Mikhail Sheila
Director
15,500 $0 15,500
(Direct)
View
2022-06-09
Option Award
2022-06-13
5:00 pm
N/A
2032-06-08
Verve Therapeutics Inc. VERV MacLean Michael F
Director
15,500 $0 15,500
(Direct)
View
2022-06-09
Option Award
2022-06-13
5:00 pm
N/A
2032-06-08
Verve Therapeutics Inc. VERV Evans John M.
Director
15,500 $0 15,500
(Direct)
View
2022-03-18
Exercise
2022-03-22
07:41 am
N/A
2030-09-15
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
69,674 $0 1,244,827
(Direct)
View
2022-03-18
Exercise
2022-03-22
07:41 am
N/A
N/A
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
69,674 $2.87 1,244,827
(Direct)
View
2022-02-11
Option Award
2022-02-15
09:00 am
N/A
2032-02-10
Verve Therapeutics Inc. VERV Dorval Allison
CFO
60,000 $0 60,000
(Direct)
View
2022-02-11
Option Award
2022-02-15
08:58 am
N/A
2032-02-10
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
332,000 $0 332,000
(Direct)
View
2022-02-11
Option Award
2022-02-15
08:57 am
N/A
2032-02-10
Verve Therapeutics Inc. VERV Bellinger Andrew
Chief Scientific Officer
125,000 $0 125,000
(Direct)
View
2022-02-11
Option Award
2022-02-15
08:56 am
N/A
2032-02-10
Verve Therapeutics Inc. VERV Ashe Andrew D.
See Remarks
125,000 $0 125,000
(Direct)
View
2022-01-04
Exercise
2022-01-06
4:36 pm
N/A
2029-04-14
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
1,870 $0 835,955
(Direct)
View
2022-01-04
Exercise
2022-01-06
4:36 pm
N/A
N/A
Verve Therapeutics Inc. VERV Kathiresan Sekar
CEO
1,870 $1.39 835,955
(Direct)
View
Goto 0, 1, 2, Next